Xu H, Liu H, Li Z, Xu Q, Lin N, & Li X. (2022). BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response. Dove Medical Press.
Chicago Style (17th ed.) CitationXu H, Liu H, Li Z, Xu Q, Lin N, and Li X. BIRC7 Is Beneficial for Melanoma Progression and Hypoxic Response. Dove Medical Press, 2022.
MLA (9th ed.) CitationXu H, et al. BIRC7 Is Beneficial for Melanoma Progression and Hypoxic Response. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.